Treats Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism. ANDA 73618, held by Dr. Reddy's Laboratories. Carbidopa; Levodopa.
As of Nov 21, 2026, ANDA 73618 (Carbidopa and Levodopa), held by Dr. Reddy's Laboratories, was first approved by FDA on Aug 28, 1992, with 14 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Carbidopa and levodopa tablets, USP are indicated in the treatment of Parkinson's disease, post-encephalitic parkinsonism, and symptomatic parkinsonism that may follow carbon monoxide intoxication or manganese intoxication. Carbidopa allows patients treated for Parkinson's disease to use much lower doses of levodopa. Some patients who responded poorly to levodopa have improved on carbidopa and levodopa tablets. This is most likely due to decreased peripheral decarboxylation of levodopa caused by administration of carbidopa rather than by a primary effect of carbidopa on the nervous system. Carbidopa has not been shown to enhance the intrinsic efficacy of levodopa.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 28, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Carbidopa and Levodopa10MG;100MG · tablet;oral | Carbidopa; Levodopa | Rx |
| Nov 5, 2015 | Supplement 27Labeling · Standard review | Approved | None posted |
| Jul 5, 2011 | Supplement 25Labeling | Approved | None posted |
| Feb 3, 2011 | Supplement 24Manufacturing | Approved | None posted |
| Oct 30, 2009 | Supplement 22Labeling | Approved | None posted |
| Jan 4, 2002 | Supplement 14Manufacturing | Approved | None posted |
| Jan 4, 2002 | Supplement 13Manufacturing | Approved | None posted |
| Nov 6, 2001 | Supplement 15Labeling | Approved | None posted |
| Dec 2, 1999 | Supplement 11Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 10Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 5Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 4Manufacturing | Approved | None posted |
| Oct 28, 1997 | Supplement 3Manufacturing | Approved | None posted |
| Dec 10, 1996 | Supplement 2Manufacturing | Approved | None posted |
| Aug 27, 1996 | Supplement 1Manufacturing | Approved | None posted |
| Aug 28, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters